Vyome Holdings, Inc. (DE:H1O)
NASDAQ:H1O
H1O Stock Chart & Stats
€0.43
--
Market closed
€0.43
--
Day’s Range― - ―
52-Week Range€0.43 - €0.43
Previous CloseN/A
VolumeN/A
Average Volume (3M)0.00
Market Cap
€13.93M
Enterprise Value€4.40M
Total Cash (Recent Filing)€8.80M
Total Debt (Recent Filing)€22.55K
Price to Earnings (P/E)―
Beta0.00
Next Earnings
Nov 24, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-38.80
Shares Outstanding7,018,528
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)3.04
Price to Sales (P/S)23.26
P/FCF Ratio-1.98
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€9.92Price Target Upside2205.96% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)-0.6
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Healthy Gross MarginA near-50% gross margin indicates the company's core product economics are solid; with scale and tighter operating control, gross profitability can support sustainable margins and give management levers to improve operating profit over time even before revenue re-acceleration.
Low Leverage And Recent Positive EquityVery low debt reduces interest burden and provides financing optionality, while recent positive equity improves balance-sheet flexibility. This structural financial cushion limits solvency risk and supports the ability to raise capital or pursue strategic pivots without heavy leverage.
Strategic Repositioning And Capital-structure TighteningA shareholder-backed share reduction plus a pivot via the Livechain/Humanyze transaction signal a durable strategic shift and governance alignment. If executed, the move into AI HR analytics represents a structural change in business focus with potential long-term market opportunity.
Bears Say
Sharp Revenue DeclineA steep drop in trailing revenue weakens scale economics and leaves fixed operating costs harder to absorb. Over an extended horizon this reduces bargaining power, limits reinvestment capacity, and makes achieving positive operating leverage more difficult without durable revenue recovery.
Persistent Negative Cash FlowMulti-year negative operating and free cash flow drains liquidity and forces reliance on external funding. Ongoing cash burn constrains strategic optionality, increases dilution risk from future financings, and undermines the company's ability to self-fund growth initiatives long term.
Multi-year Losses And Poor ReturnsSustained large losses and negative ROE indicate the business has not yet reached a profitable scale. Persistent unprofitability erodes retained capital, makes compounding value unlikely without change, and raises execution risk for any strategic pivot.
Vyome Holdings News
H1O FAQ
What was Vyome Holdings, Inc.’s price range in the past 12 months?
Vyome Holdings, Inc. lowest stock price was €0.43 and its highest was €0.43 in the past 12 months.
What is Vyome Holdings, Inc.’s market cap?
Vyome Holdings, Inc.’s market cap is €13.93M.
When is Vyome Holdings, Inc.’s upcoming earnings report date?
Vyome Holdings, Inc.’s upcoming earnings report date is Nov 24, 2026 which is in 161 days.
How were Vyome Holdings, Inc.’s earnings last quarter?
Vyome Holdings, Inc. released its earnings results on May 28, 2026. The company reported -€0.129 earnings per share for the quarter, the consensus estimate of -€0.129 by €0.
Is Vyome Holdings, Inc. overvalued?
According to Wall Street analysts Vyome Holdings, Inc.’s price is currently Undervalued.
Does Vyome Holdings, Inc. pay dividends?
Vyome Holdings, Inc. does not currently pay dividends.
What is Vyome Holdings, Inc.’s EPS estimate?
Vyome Holdings, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vyome Holdings, Inc. have?
Vyome Holdings, Inc. has 7,018,528 shares outstanding.
What happened to Vyome Holdings, Inc.’s price movement after its last earnings report?
Vyome Holdings, Inc. reported an EPS of -€0.129 in its last earnings report, expectations of -€0.129. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Vyome Holdings, Inc.?
Currently, no hedge funds are holding shares in DE:H1O
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vyome Holdings, Inc.
Vyome Holdings, Inc. operates as a healthcare firm currently in its clinical development phase, concentrating on the creation of innovative medicinal treatments designed to address both immuno-inflammatory conditions and infrequent disorders. Founded in 2017, the company extends its market reach throughout the United States and into global territories, headquartered in Princeton, New Jersey.
H1O Stock 12 Month Forecast
Average Price Target
€9.92
▲(2205.96% Upside)
Technical Analysis
Options Prices
Currently, No data available
---